Last Updated : Jan 12, 2018 02:58 PM IST | Source: CNBC-TV18

Hold GlaxoSmithKline Pharmaceuticals, says Avinnash Gorakssakar

According to Avinnash Gorakssakar, Market Expert, one may hold GlaxoSmithKline Pharmaceuticals

CNBC TV18 @moneycontrolcom

Avinnash Gorakssakar, Market Expert  told CNBC-TV18, "One can hold on to GlaxoSmithKline Pharmaceuticals because I would believe that this is one company which definitely could deliver good amount of returns over the next say one to two years. I think this is a stock which does not enjoy much liquidity but considering the fact that the pharma cycle is now slow turning around and hopefully I think the way things should pan out for CY2019 I think GlaxoSmithKline Pharmaceuticals should definitely do reasonably better."

"I think keeping 18-24 month kind of horizon one could definitely expect a decent risk reward. Maybe in the short term the stock may not go anywhere, but longer term definitely good risk reward could be made by the investor," he added.
First Published on Jan 12, 2018 02:58 pm
Follow us on
Available On
PCI DSS Compliant